Azim Dharani is involved with simulation studies of biological systems. Azim received a B.S. in chemistry from Duke University, and earned a master’s degree in chemistry from the University of Cambridge, where he developed enzyme-electrode hybrids capable of converting atmospheric carbon dioxide into biofuels. As an undergraduate researcher in Katherine Franz’s lab, Azim successfully designed and characterized copper-binding drugs that inhibit metastatic prostate cancer growth. In his free time, he enjoys cooking, running, and going to stand-up comedy shows in the city.